David Requena

Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy

Diego Chowell, Luc G.T. Morris, Claud Grigg et al. · Science · 2017 · 1.2K citations

Life Sciences, Immunology, Oncology +17

<i>DNAJB1–PRKACA</i> fusion kinase interacts with β-catenin and the liver regenerative response to drive fibrolamellar hepatocellular carcinoma

Edward R. Kastenhuber, Gadi Lalazar, Shauna L Houlihan et al. · Proceedings of the National Academy of Sciences · 2017 · 162 citations · Full text

Medicine, Molecular Biology, Oncology +17

A Human Organoid Model of Aggressive Hepatoblastoma for Disease Modeling and Drug Testing

James A. Saltsman, William J. Hammond, Nicole J.C. Narayan et al. · Cancers · 2020 · 59 citations · Full text

Medicine, Cancer Biology, Oncology +16

Origins and Specification of the Drosophila Wing

David Requena, Jose Andres Álvarez, Hugo Gabilondo et al. · Current Biology · 2017 · 47 citations · Full text

Life Sciences, Biology, Developmental Biology +12

Identification of Novel Therapeutic Targets for Fibrolamellar Carcinoma Using Patient-Derived Xenografts and Direct-from-Patient Screening

Gadi Lalazar, David Requena, Lavoisier Ramos‐Espiritu et al. · Cancer Discovery · 2021 · 47 citations · Full text

Medicine, Oncology, Pharmacology +13